Sword Bio Appoints Nina Sahay, as Head of Quality Assurance
Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of Nina Sahay as Associate Director of Quality Assurance.
Nina Sahay, RQAP-GLP joins Sword Bio as the Associate Director of Quality Assurance and brings with her over 20 years of experience in the regulated pharmaceutical and laboratory sectors. She brings extensive experience in system validations, regulated training, mentorship, and regulated investigations to name a few. Prior to joining Sword Bio, Nina served for over 7 years as the Senior Quality Assurance Specialist at Charles River Laboratories where she was the site lead for all client audits, led global teams and trained professionals of all levels. She has immense experience in harmonizing processes across sites and is a passionate leader with a versatile background.
Nina has been a Registered Quality Assurance Professional in the Good Laboratory Practices for over 13 years and has been a member of the MidWest chapter as well as the national Society of Quality Assurance for over 16 years.
“At Sword, quality is not just a standard—it’s embedded in our culture,” said David Dingott, CEO. “I’m confident that under Nina’s leadership, this focus on excellence will continue to drive our success as we scale.”
“I’ve been fortunate in my career to work with and learn from industry thought leaders. I intend to continue fostering compliance excellence and supporting a culture of high quality at Sword Bio while maintaining transparent communication of information with our clients. I look forward to contributing to the ongoing success and growth of Sword Bio.’”
About Sword
Sword Bio is a bioanalytical CRO that partners with biotech and pharma companies to deliver data essential to their drug development needs. The Sword team is built with experts in assay development, validation and sample analysis under Non-GLP or GLP. We support our clients with PK, immunogenicity, and biomarker assays for pre-clinical and clinical studies.
Sword’s team of highly experienced scientists ensures high-quality science, data integrity and regulatory compliance through all phases of drug development. We pride ourselves on starting projects quickly and delivering on-time quality data, so that our clients can quickly and efficiently achieve their goals.
For more information, visit www.swordbio.com.